Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
Cardiovascular disease (CVD) is an evolving process that begins in the early stages of chronic kidney disease (CKD) in children. Several surrogate markers, such as ambulatory blood pressure monitoring (ABPM), left ventricular (LV) mass, and arterial stiffness assessment, allow for the early detectio...
Main Authors: | Wei-Ling Chen, You-Lin Tain, Hung-En Chen, Chien-Ning Hsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2021.706323/full |
Similar Items
-
Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease
by: You-Lin Tain, et al.
Published: (2022-10-01) -
Pregnancy Zone Protein as an Emerging Biomarker for Cardiovascular Risk in Pediatric Chronic Kidney Disease
by: Wei-Ling Chen, et al.
Published: (2023-09-01) -
Complement Factor H and Related Proteins as Markers of Cardiovascular Risk in Pediatric Chronic Kidney Disease
by: Wei-Ting Liao, et al.
Published: (2022-06-01) -
The First Thousand Days: Kidney Health and Beyond
by: Chien-Ning Hsu, et al.
Published: (2021-10-01) -
Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
by: Monique F. M. Santana, et al.
Published: (2020-09-01)